tributyrin has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breitman, TR; Chen, ZX | 1 |
| Pekrun, A; Schmejkal, S; Witt, O | 1 |
2 other study(ies) available for tributyrin and Di Guglielmo Disease
| Article | Year |
|---|---|
Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Topics: Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Friend murine leukemia virus; Glycerides; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Prodrugs; Triglycerides; Tumor Cells, Cultured | 1994 |
Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells.
Topics: Antineoplastic Agents; Fetal Hemoglobin; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Tretinoin; Triglycerides | 2000 |